5,483 results on '"AbbVie"'
Search Results
102. The CROCO Study: CROhn's Disease COhort Study (CROCO)
103. Sequential Regimen of Bendamustine-Debulking Followed by ABT-199 and GA101-Induction and -Maintenance in CLL (CLL2-BAG)
104. Rituximab, Bendamustine and Cytarabine Followed by Venetoclax in High Risk Elderly Patients With MCL
105. Venetoclax After TKI to Target Persisting Stem Cells in CML (VARIANT)
106. Study of Venetoclax in Combination With Decitabine in Subjects With Acute Myeloid Leukemia
107. Hypofractionated Whole-Pelvis Radiotherapy (WPRT) vs Conventionally-Fractionated WPRT in Prostate Cancer (HOPE)
108. Health Coaching as a Tool for Improving Medication Adherence in Adult Patients With Inflammatory Bowel Disease
109. MHH-HCV-NPM-Neuropsychiatric Manifestations of HCV-infection During and After Treatment With OBV/PTV/r and DSV
110. Venetoclax Plus Azacitidine Versus Intensive Chemotherapy for Fit Patients With Newly Diagnosed NPM1 Mutated AML (VINCENT)
111. Venetoclax in Combination With 5 Days Azacitidine in Untreated AML Patients, Not Eligible for Standard Induction Therapy (VENAZA-5S)
112. Risankizumab Long-term Remission Study
113. An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
114. Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
115. Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms
116. A Study on the Safety of GEN1044 (DuoBody®-CD3x5T4) in Patients With Malignant Solid Tumors
117. Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDS
118. Venetoclax Plus Inotuzumab for B-ALL
119. Phase II Study of Ilorasertib (ABT348) in Patients With CDKN2A Deficient Solid Tumors
120. Croatian Version of the Ocular Surface Disease Index Questionnaire (OSDI) (Cro-OSDI)
121. Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
122. A Phase II Study Using Rituximab Plus Venetoclax in the Front Line Treatment of Marginal Zone Lymphoma
123. A Phase 1 Study of ABBV-CLS-7262, Rosuvastatin, and Digoxin in Healthy Subjects
124. A Trial COmparing staNdard of Care Versus Treat to Target With telemonitoRing and Patient Education in Patients With Ulcerative cOlitis Initiating Adalimumab (CONTROL)
125. Expanded Access Program for Epcoritamab
126. JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors
127. HCV RNA Fingerstick Assay as Useful Point of Care of Diagnostic Tool for Drug Users in Brussels
128. Fluorescence Imaging of IBD and RA Using Adalimumab-800CW (STRATIFY)
129. PsoBest - The German Psoriasis Registry
130. TDM Guided Early Optimization of ADAL in Crohn's Disease
131. An Investigational Immuno-therapy Study of Nivolumab, Pomalidomide and Dexamethasone Combinations in Patients With Multiple Myeloma (CheckMate 602)
132. Post Acute Pancreatitis Pancreatic Exocrine Insufficiency (PAPPEI)
133. French Observational Study of Patients With Chronic Lymphocytic Leukemia Or Small Lymphocytic Lymphoma in Real-World Settings (FOLLOW)
134. Impact of Hidradenitis Suppurativa on Quality of Life Functions
135. Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL (CLL2-GiVe)
136. CLassification of Axial SpondyloarthritiS Inception Cohort (CLASSIC)
137. Guideline for Hometitration With Duodopa for Parkinson Patients
138. An Investigational Immuno-therapy Trial of Pomalidomide and Low-dose Dexamethasone With or Without Elotuzumab to Treat Refractory and Relapsed and Refractory Multiple Myeloma (ELOQUENT-3)
139. Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Newly Diagnosed, Previously Untreated Multiple Myeloma (ELOQUENT - 1)
140. Single-dose PK Study of Ceftazidime-Avibactam In Hospitalized Children Receiving Systemic Antibiotics for Nosocomial Pneumonia
141. Treatment of Recently Acquired Hepatitis C With the 3D Regimen or G/P (TARGET3D)
142. Crohn's Disease Endoscopic REmission Definition in an Objective Way (CREDO1)
143. Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up (CREDO2)
144. Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia (ERADIC)
145. Phase II Study of Lenalidomide/Dexamethasone With or Without Elotuzumab for Newly Diagnosed MM Patients in Japan
146. Evaluating the Chain of Addiction Care (CAC) (HepC:CAC)
147. Study of Oral Ibrutinib Capsules to Assess Respiratory Failure in Adult Participants With Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Pulmonary Injury (iNSPIRE)
148. Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma (ELOQUENT - 2)
149. Optimal Dose Finding Study ABT-199 and Ibrutinib in MCL
150. Cariprazine Versus Placebo for Social Anxiety Disorder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.